Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors.
Skobridis K, Kinigopoulou M, Theodorou V, Giannousi E, Russell A, Chauhan R, Sala R, Brownlow N, Kiriakidis S, Domin J, Tzakos AG, Dibb NJ.
Skobridis K, et al. Among authors: kiriakidis s.
ChemMedChem. 2010 Jan;5(1):130-9. doi: 10.1002/cmdc.200900394.
ChemMedChem. 2010.
PMID: 19950162